1 Ryan J. Beechinor, PharmD, UC Davis Comprehensive Cancer Center, Sacramento, CA, UCSF School of Pharmacy, San Francisco, CA; Ryan J. Beechinor, PharmD, Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS, University of Kansas Medical Center, Westwood, KS; and Ryan J. Beechinor, PharmD, Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.